Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes...
Leadership
Ronald C. Renaud Jr., M.B.A.
President, CEO & Director
Paul Douglas Burgess J.D., M.S.
Chief Operating & Business Officer
Jamie Beth Coleman
Chief Commercial Officer
Douglas W. Pagan M.B.A.
Chief Financial Officer
Maura Gavaghan
Vice President of Corporate Communications & Investor Relations
